Unicycive Therapeutics, Inc.
SEC CIK 1766140 · UNCY · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Laumas Sandeep | Director | filed 2021 - 2026 |
| Gupta Shalabh K. | Director · CEO & President | filed 2021 - 2026 |
| Kenkare-Mitra Sara | Director | filed 2023 - 2026 |
| Aggarwal Gaurav | Director | filed 2023 - 2025 |
| Ryan John L | Director | filed 2021 - 2023 |
| Schiller Brigitte | Director | filed 2021 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Townsend John | Chief Financial Officer | filed 2021 - 2026 |
| Gupta Pramod | EVP, Pharmaceuticals and BD | filed 2021 - 2026 |
| Jermasek Douglas | EVP, Corporate Strategy | filed 2022 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.